Shares of Sage Therapeutics Inc. surged after Biogen Inc. offered to acquire the neuroscience-focused drugmaker for about $469 million.
Sage Therapeutics Jumps on Biogen’s $469 Million Takeover Offer
Estimated read time
1 min read
+ There are no comments
Add yours